GlassScriptPhysician profile
Bright Benfor
NPI 1871343756
$831.13
in general payments reported to CMS, 2019-2025
13 companies · $744 in 2025
The $744 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $87.39 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $122.25 | 2025 | |
| Medtronic, INC. | $114.70 | 2025 | Endurant Iis, Valiant Captivia |
| Organogenesis INC. | $110.46 | 2025 | Puraply Wound Matrix |
| Stryker Corporation | $106.68 | 2025 | Artix Mt |
| Angiodynamics, INC. | $87.39 | 2024 | Alphavac |
| Penumbra, INC. | $86.74 | 2025 | Ruby Coil |
| Boston Scientific Corporation | $66.03 | 2025 | Ranger, Ekosonic |
| Imperative Care, INC | $43.53 | 2025 | Symphony Catheter |
| Teleflex LLC | $22.93 | 2025 | Quikclot |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.91 | 2025 | Xifaxan |
| Abiomed | $20.52 | 2025 | |
| Ethicon US, LLC | $15.08 | 2025 | Ethicon |
| Terumo Medical Corporation | $13.91 | 2025 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bright Benfor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.